Sonescence is a clinical-stage, specialty pharmaceutical company that uses a novel, ultrasound augmented drug-delivery platform, to create transformative solutions for various molecules, where a shift from IV to Sub-Q administration offers tailored, local delivery of drug payloads without systemic side-effects.